scholarly journals Percutaneous Management of Prosthetic Valve Dysfunction in Mitral Position: Transapical Mitral Valve-In-Valve Implantation

2019 ◽  
Vol 87 (5) ◽  
pp. 380-382
Author(s):  
Juan R. Alderete ◽  
Alberto C. Anaya Revolledo ◽  
Verónica I. Volberg ◽  
Miguel Rubio ◽  
Gustavo E. Barrera ◽  
...  
2018 ◽  
Vol 93 (6) ◽  
pp. 1087-1094 ◽  
Author(s):  
Timothy A. Joseph ◽  
Mackram F. Eleid ◽  
Allison K. Cabalka ◽  
Joseph F. Maalouf ◽  
Charanjit S. Rihal

2018 ◽  
Vol 23 (1) ◽  
pp. 37-47 ◽  
Author(s):  
Ludmil Mitrev ◽  
Nayan Desai ◽  
Ahmed Awad ◽  
Sajjad Sabir

The past 2 decades have seen a proliferation of transcatheter mitral valve (MV) therapies, which are less invasive and distinct from surgical MV repair or replacement. The commonly used MV transcatheter therapies include (1) percutaneous mitral balloon commissurotomy (PMBC) for rheumatic mitral stenosis; (2) edge-to-edge repair with the MitraClip for mitral regurgitation; (3) valve-in-valve implantation in bioprosthetic MV, native MV, or mitral ring; and (4) closure of paravalvular leaks (PVLs). This article will focus on the use of echocardiography in the diagnosis, patient selection, procedural guidance, and postprocedural follow-up for PMBC, with notes on the role of transesophageal echocardiography in transcatheter interventions for prosthetic valve degeneration and PVL closure.


2013 ◽  
Vol 61 (17) ◽  
pp. 1759-1766 ◽  
Author(s):  
Anson Cheung ◽  
John G. Webb ◽  
Marco Barbanti ◽  
Melanie Freeman ◽  
Ronald K. Binder ◽  
...  

2017 ◽  
Vol 19 (1) ◽  
pp. 122
Author(s):  
Yan Sun ◽  
Hui Ming Zhang ◽  
Hao Wang

A rare case of mechanical prosthetic valve dysfunction in mitral position. The mechanical valve opened once every two cardiac cycles. We also found the opening time of the mechanical valve in aortic positions was long and short alternately because of the Left ventricular volume changed every cardiac cycles.


2015 ◽  
Vol 19 (2) ◽  
pp. 36 ◽  
Author(s):  
L. S. Barbarash ◽  
A. N. Stasev ◽  
S. G. Kokorin ◽  
N. V. Rutkovskaya ◽  
I. N. Sizova

<p><strong>Background</strong>. Patients with bioprosthetic valve dysfunction have a higher risk for redo procedures because of advanced age, comorbidities and redo-related technical difficulties. Thus, valve-in-valve replacement seems to be an easier and safer option for this group of patients.<br />Objective. To assess the immediate results of mitral valve-in-valve implantation for bioprosthetic valve dysfunction.<br /><strong>Methods</strong>. 6 patients underwent mitral valve-in-valve implantation using “UniLine” prostheses at Kemerovo Research Institute for Complex Problems of Cardiovascular Diseases in 2014.<br /><strong>Results.</strong> There were no cases of in-hospital deaths and prosthesis-related complications in the group under study. Satisfactory performance of bioprostheses was confirmed by echocardiography offered to all the patients before their discharge. <br /><strong>Conclusion.</strong> Mitral valve-in-valve implantation for bioprosthetic valve dysfunction allows achieving satisfactory immediate results.</p>


2012 ◽  
Vol 1 (2) ◽  
pp. 55-61 ◽  
Author(s):  
Alireza Alizadeh-Ghavidel ◽  
Yalda Mirmesdagh ◽  
Mehrzad Sharifi ◽  
Anita Sadeghpour ◽  
Reza Nakhaeizadeh ◽  
...  

2016 ◽  
Vol 55 (5) ◽  
pp. 479-483 ◽  
Author(s):  
Tetsuro Yokokawa ◽  
Takahiro Ohara ◽  
Seiji Takashio ◽  
Mari Sakamoto ◽  
Yuko Wada ◽  
...  

2016 ◽  
Vol 22 (4) ◽  
pp. 501-503 ◽  
Author(s):  
Isabel Baldizon ◽  
Andres Espinoza ◽  
Thomas Kuntze ◽  
Evaldas Girdauskas

2013 ◽  
Vol 61 (10) ◽  
pp. E1750
Author(s):  
Marco Barbanti ◽  
John Webb ◽  
Freeman Melanie ◽  
Ronald Binder ◽  
Christopher Thompson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document